A key reason positions haven't been filled is that they require travel that ranges from 25% to 75% of the time.

“FDA has not yet developed action plans to fully address travel, workload, and work-life balance because potential solutions ...

The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

The environmental lawyer’s many controversial statements are rallying state lawmakers to pay close attention to Connecticut’s ...

Aucatzyl is the first CAR-T cell therapy approved by the FDA with no requirement for a risk evaluation mitigation strategy ...

Almost every food brand has been affected by product recalls at some point, and Hostess is no different. These are some of ...

Johnson & Johnson MedTech announced today that the FDA granted its Ottava surgical robot investigational device exemption ...

Less than a month after the FDA removed Eli Lilly’s tirzepatide from its shortage list, the agency has done the same for Novo Nordisk’s rival GLP-1 semaglutide, potentially signaling the end of a d | ...

CA1 is the first and only treatment for chemotherapy-induced diarrhea (CID) in dogs to receive any type of approval from the FDA ...

Supernus Pharmaceuticals is reaping the benefits of its ADHD drug Qelbree, with strong Q3 results and upwardly revised ...